Last updated: 4 months ago
Portage Biotech Inc. Unveils Cyncado Therapeutics™: A Bold New Chapter
On January 6, 2025, Portage Biotech Inc. re-launches Cyncado Therapeutics™ with CEO Peter Molloy, focusing on adenosine receptor antagonists. Key insights from the Form 6-K.